AzTrials
AzTrials

Cardiovascular DiseaseNCT02163031

Left vs. Right Radial Approach for Routine Catheterization of Heart Transplant Patients

A study testing devices used in the coronary angiography in people with Cardiovascular Disease, run by Hospital Clinic of Barcelona at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Orthotopic heart transplantation is a well established therapeutic measure for end stage heart failure, leading to significant improvements in survival and quality of life. In the routine clinical practice, orthotopic heart transplantation patients receive periodic cardiac catheterization for early detection of… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiovascular Disease
What is being tested?
devices used in the coronary angiography
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteSpain
Study dates
Jun 2014to Jan 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

None listed.

Who cannot join

  • chronic renal insufficiency (creatinine >2.0 mg/dl) with the potential necessity of using the radial artery as a native fistula will be considered one of the exclusion criteria;
  • in case of an abnormal or doubtful bilateral Allen's test, a pletysmography will be done. The presence of a type A or B curve will be considered a marker of adequate hand collaterals and the procedure will be able by this access. Only the presence of bilateral type C or D curves will be considered a contraindication to trans radial approach.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital Clinic

    Barcelona, 08036

Other trials in Spain

About this study

Official title: RADIAL 2 Heart Transplant Study: Left vs. Right Radial Approach Randomized Comparison for Routine Catheterization of Heart Transplant Patients

Orthotopic heart transplantation is a well established therapeutic measure for end stage heart failure, leading to significant improvements in survival and quality of life. In the routine clinical practice, orthotopic heart transplantation patients receive periodic cardiac catheterization for early detection of allograft vascular disease.

The coronary angiography of these patients is characterized for several technical difficulties, generally related to the presence of the aortotomy with anomalous implantation of the coronary ostia and to the orthotopic position of the allograft. For these reasons, trans femoral approach is usually preferred. In the last two decades, trans radial approach for coronary angiography emerged to be effective, safe and able to improve patient comfort. However, there is no universal consensus on the optimal choice of radial access from either the left or the right artery. Currently, this choice is largely dependent on the operator's preference. The trans right radial approach is generally preferred in routine clinical practice mainly due to its easier catheter manipulation for the operators from patient's right side, and the current design of radial compression devices for the right wrist in medical market. As such, a major barrier to prevent the wide adoption of the left radial access lies in some difficulty to reach the left wrist leaning over the patient, particularly for shorter operators or in obese patients. However, a great deal of attention has been recently directed toward the trans left radial access, as it has an important anatomical advantage due to the vascular anatomy of epiaortic vessels with a straighter route to the left coronary ostium, which could also reduce the risk of cerebrovascular complications.

Read more

However, no data are available about the performance of trans left radial or trans-right radial approach in coronary angiography orthotopic heart transplantation patients. However, in this particular setting of patients, the left radial approach might reduce the technical difficulties related to the anatomical variations.

In this single centre, prospective, randomized study, we sought to compare trans right radial versus trans left radial approach in terms of amount of contrast medium, radiation exposure, number of catheters used, cross over to the other access site rate and local and systemic complications in orthotopic heart transplantation patients.

Read the detailed description

Orthotopic heart transplantation is a well established therapeutic measure for end stage heart failure, leading to significant improvements in survival and quality of life. Allograft vascular disease remains the most frequent cause of morbidity and mortality after orthotopic heart transplantation, with angiographic evidence of allograft vascular disease around 50% of patients at 5- to 15-year follow-up. In the routine clinical practice, orthotopic heart transplantation patients receive periodic cardiac catheterization for early detection of allograft vascular disease.

The coronary angiography of these patients is characterized for several technical difficulties, generally related to the presence of the aortotomy with anomalous implantation of the coronary ostia and to the orthotopic position of the allograft. For these reasons, trans femoral approach is usually preferred. In the last two decades, trans radial approach for coronary angiography emerged to be effective, safe and able to improve patient comfort. However, there is no universal consensus about the optimal choice of radial access from either the left or the right artery. Currently, this choice is largely dependent on the operator's preference. The trans-right-radial approach is generally preferred in routine clinical practice mainly due to its easier catheter manipulation for the operators from patient's right side, and the current design of radial compression devices for the right wrist in medical market. As such, a major barrier to prevent the wide adoption of the left radial access lies in some difficulty to reach the left wrist leaning over the patient, particularly for shorter operators or in obese patients. However, a great deal of attention has been recently directed toward the trans-left-radial access, as it has an important anatomical advantage due to the vascular anatomy of epiaortic vessels with a straighter route to the left coronary ostium, which could also reduce the risk of cerebrovascular complications.

In this context, a recent metanalysis demonstrated that trans left radial access is preferable to trans-right-radial approach in terms of fluoroscopy time and contrast use for the diagnostic or interventional coronary procedures. Moreover, as expected, there was an indication of lowered failure rate of radial access from the left than the right. No data are available about the performance of trans left radial access or trans right radial approach in coronary angiography of orthotopic heart transplantation patients. However, in this particular setting of patients, the trans-left-radial access might reduce the technical difficulties related to the anatomical variations.

In this single-centre, prospective, randomized study, we sought to compare trans right radial approach versus trans-left-radial access in terms of amount of contrast medium, radiation exposure, number of catheters used, cross-over to the other access site rate and local and systemic complications in orthotopic heart transplantation patients.

Study objectives

  1. To demonstrate the superiority of trans left radial access, compared to trans right radial approach during coronary angiography of orthotopic heart transplantation patients, in terms of amount of contrast medium, radiation exposure, number of catheters used, cross-over to other access site rate local and systemic complications
  2. To determine the relationship of operator experience with radiation exposure to answer the question that whether we can minimize fluoroscopy time with increased operator experience ("post-hoc analysis");
  3. To assess the cost effectiveness of coronary angiography performed by trans right radial approach versus trans left radial access ("post hoc analysis").

Method section Clinical data A detailed anamnesis of each trial participant will be collected: age, gender, weight, high, BMI, coronary risk factors (hypertension, dyslipemia, diabetes mellitus, smoking habit, obesity), cause of transplantation, date of transplantation, current clinical status and therapy, ejection fraction, renal function and complete blood count. In particular, creatinine values will be evaluated at baseline, 3-4 days after the interventional procedure and, if impaired, also at 7-10 days from the coronary angiography.

Procedure Participating interventional cardiologists will be high-volume radial operators (meeting minimal proficiency criteria of ≥50% interventional cases by radial approach per year). Each variable will be analyzed separately in consultants, fellows, and post graduate fellows (trainees). In particular, participating interventional cardiologists will be divided in well experienced radial operators (defined as the person who has performed >500 radial procedures including >200 procedures in a recent year), less experienced (the person who has done 200-500 radial procedures in a recent year), and trainee (the person who has done <200 radial procedures). The procedures will be performed according to current guidelines. At the end of the coronary angiography, after introducer removal, a hand wrist compression device (TR Band, Terumo) will be used in the both group.

The procedural time was measured from the arterial puncture up to vascular hemostasis.

The radiation exposure will be measured using:

  1. dose area product meters, which reflects both the dose of radiation administered and the area on the patient it is administered to. This is a continuous variable measured in microgray meter squared (μGym2).
  2. fluoroscopy time, which reflects the length of time the patient and operator are exposed to radiation;
  3. total dose, measured in milligray (mGy), administered from the angiography system.

The amount of contrast medium for each procedure will be recorded. The number and type of catheters employed as well as the number and the type of wires used in the interventional procedure will be detected.

The cross-over to other access site were also collected. In addition, systemic and vascular complications will be evaluated pre-discharge.

In particular, vascular complications will be defined as haemoglobin loss at least 2 mmol/l, necessity of a blood transfusion and vascular repair, hematoma, pseudoaneurysm and arterial occlusion. The renal failure after procedure will be defined as a raise in serum values of creatinine ≥ 0.5 mg/dl or ≥ 25% within 24-72 hours after the exposure to the contrast medium.

Statistical Analysis

All clinical and procedural characteristics will be summarized as mean ± Standard Deviation for continuous variables with normal distribution, median (interquartile range) for those continuous but with skewed distribution, and number (percentage) for categorical variables; The Student t, Mann-Whitney U and Fisher exact tests will be computed when appropriate for bivariate analyses. Firstly, all analyses will be conducted on intention to treat basis, regardless possible access site cross-over. Afterwards, efficacy subset analyses will be performed. A two-tailed p-value <0.05 will be considered statistically significant. Data will be analyzed using SPSS for Windows version 20.0 software (SPSS Inc. Chicago, USA). The sample size will be calculated in order to provide, with a 80% power, the difference of 20 ml with a Standard Deviation of ± 30 of amount of contrast dose (alpha value=0.05) between trans-left-radial access vs. trans-right-radial access.

Being tested
devices used in the coronary angiography
Keywords
heart transplant, radial approach, catheterization
Medical subject headings
Cardiovascular Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • devices used in the coronary angiographyDevice

    Also called catheters, wires, contrast medium

    devices used in coronary angiography by left or right radial route

Study groups in NCT02163031
Study groupRoleWhat they receive
right radial approachActive comparatordevices used in the coronary angiography by right radial approach
Receives: Device: devices used in the coronary angiography
left radial approachActive comparatordevices used in the coronary angiography by left radial approach
Receives: Device: devices used in the coronary angiography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Superiority of trans-left radial approach vs. trans right radial approach in terms of amount of contrast medium.

    Measured: 1 week

Secondary outcomes (5)
  1. Superiority of trans-left radial approach in terms of procedural time

    Measured: 1 week

  2. Superiority of trans-left radial approach vs. trans-right radial approach in terms of radiation exposure (dose area product, fluoroscopy time, total dose administered from the angiography system)

    Measured: 1 week

  3. Superiority of trans-left radial approach vs. trans-right radial approach in terms of number of catheters used

    Measured: 1 week

  4. Superiority of trans-left radial approach vs. trans-right radial approach in terms of 4) cross-over to the other access site rate

    Measured: 1 week

  5. Superiority of trans-left radial approach vs. trans-right radial approach in terms of 5) local and systemic complications

    Measured: 1week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2014 (estimated)
  2. Study startJun 2014
  3. Primary completionDec 2016
  4. Study completionJan 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02163031
Sponsor's protocol ID
0187635
Status last verified
Jul 2017
First submitted
9 Jun 2014
Last updated
26 Jul 2017
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes: If requested for meta-analysis.

Publications

  • Norgaz T, Gorgulu S, Dagdelen S. A randomized study comparing the effectiveness of right and left radial approach for coronary angiography. Catheter Cardiovasc Interv. 2012 Aug 1;80(2):260-4. doi: 10.1002/ccd.23463. Epub 2012 Feb 14.

    PubMed 22334420
  • Biondi-Zoccai G, Sciahbasi A, Bodi V, Fernandez-Portales J, Kanei Y, Romagnoli E, Agostoni P, Sangiorgi G, Lotrionte M, Modena MG. Right versus left radial artery access for coronary procedures: an international collaborative systematic review and meta-analysis including 5 randomized trials and 3210 patients. Int J Cardiol. 2013 Jul 1;166(3):621-6. doi: 10.1016/j.ijcard.2011.11.100. Epub 2011 Dec 20.

    PubMed 22192284
  • Sciahbasi A, Romagnoli E, Burzotta F, Trani C, Sarandrea A, Summaria F, Pendenza G, Tommasino A, Patrizi R, Mazzari M, Mongiardo R, Lioy E. Transradial approach (left vs right) and procedural times during percutaneous coronary procedures: TALENT study. Am Heart J. 2011 Jan;161(1):172-9. doi: 10.1016/j.ahj.2010.10.003.

    PubMed 21167351

Questions about this trial

What is this clinical trial studying?

A study testing devices used in the coronary angiography in people with Cardiovascular Disease, run by Hospital Clinic of Barcelona at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Superiority of trans-left radial approach vs. trans right radial approach in terms of amount of contrast medium. (time frame: 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02163031, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jul 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in